Phase I-II-Projekt

Objective of the Phase I/II working group is the interdisciplinary conception, initiation and coordination of phase I/II studies. The consortium not only conducts investigator initiated, academic studies, but also represents a suitable portal to communicate and coordinate studies initiated by pharmaceutical companies. In addition, an interdisciplinary network has been established to perform an extensive biological study programme.

Due to the participation of a multitude of experienced European study centres, simultaneous recruitment of several trials is feasible.


Coordinator: V. Ribrag, Institute Gustave Roussy

Corporate Partners - Individual Sponsors
Mon, 20th June 2022 to Tue, 21th June 2022
Phase I/II Meeting
more dates
Mon, 24th January 2022
New members of the European MCL board
more news